Sunday, July 20, 2025 10:23 AM

Tag: Longeveron

Longeveron Inc. ($LGVN) Advances Cellular Therapy Laromestrocel for Rare Heart Condition

Staff Writer -
Longeveron Inc. (LGVN) has completed full enrollment in its Phase 2b clinical trial for laromestrocel, targeting Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric...
Our platform offers actionable news and data on events that could sway financial markets. At Catalyst DAILY, we monitor a wide variety of market catalysts, which are essential events or announcements that can trigger significant price movements in stocks, currencies, or entire sectors.

OUR WEBSITE STRICTLY PROHIBITS ANY FORM OF PROMOTION OR TOUTING
Contact us: info@catalystdaily.com
© Catalyst Daily 2025